IONS

News GSK, Ionis mark late-stage trial win for chronic hepatitis B therapy

5d ago

News Ionis, Alnylam, BioMarin up as Citi starts at Buy on catalyst and growth outlook

13d ago

News Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market

14d ago

News Ionis Pharmaceuticals Reveals 'Unprecedented Results' From Rare Neurological Disease Trial

14d ago

News Ionis Pharma Wins FDA Nod For First RNA-Targeted Therapy For Rare Genetic Swelling Disorder

14d ago

News Ionis Pharma Beats Expectations for Q4

14d ago

News Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?

14d ago

News Leerink Partners upgrades Ionis stock on key asset commercialization - Investing.com

14d ago

News The Latest Analyst Ratings For Ionis Pharmaceuticals - Benzinga

14d ago

News Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts

14d ago

News FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen

14d ago

News Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug

14d ago

News Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results

14d ago

News Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)

14d ago

News Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

14d ago

News Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile

14d ago

News Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

14d ago

News GSK Targets China's Hepatitis B Market Through New Deal

22d ago

Insider trade Sale by Joseph Loscalzo

26d ago

Insider trade Sale by Joseph Klein III

27d ago

Insider trade Sale by Joseph Baroldi (EVP, Chief Business Officer)

32d ago

News Ionis Pharmaceuticals beats top-line and bottom-line estimates; introduces FY26 outlook

34d ago

SEC filing IONS Reports $246M Q1 Rev, $118M Op Loss, Raises >$3B Oleza Sales Guidance, FDA Accepts sNDA, Zilganersen NDA Reviewed

34d ago

SEC filing IONS Reports $12B Revenue, $3.4B Net Income, +94% YoY

42d ago

Insider trade Sale by Lynne B Parshall

45d ago